Latest news
Trastuzumab Rezetecan Improves Progression-Free Survival in HER2-Positive Metastatic Breast Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 14:42:22 GMTAcalabrutinib May Offer Durable Results in CLL Treatment - MedscapeMedscape · Fri, 07 Aug 2026 13:09:21 GMTOmitting Axillary Dissection Preserves Survival and Arm Function in SENOMAC - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 16:08:57 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:00:43 GMTEnfortumab Vedotin-Induced Skin Reactions Linked to Better Survival - EMJEMJ · Wed, 05 Aug 2026 13:08:08 GMTDoes ERBB2-Low Predict Poor Survival in Gastric Cancer? - MedscapeMedscape · Wed, 05 Aug 2026 12:29:16 GMTReal-World Analysis Explores GLP-1 Use and Overall Survival - Targeted OncologyTargeted Oncology · Tue, 04 Aug 2026 22:08:47 GMTProphylactic Cranial Irradiation Improves Survival in Limited-Stage SCLC - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:08:44 GMT